These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1961009)

  • 1. Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.
    Kano Y; Sakamoto S; Kasahara T; Akutsu M; Inoue Y; Miura Y
    Leuk Res; 1991; 15(11):1059-66. PubMed ID: 1961009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell line.
    Kano Y; Suzuki K; Akutsu M; Suda K
    Leukemia; 1992 May; 6(5):440-5. PubMed ID: 1593909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ICRF-154 in combination with other anticancer agents in vitro.
    Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
    Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CPT-11 in combination with other anti-cancer agents in culture.
    Kano Y; Suzuki K; Akutsu M; Suda K; Inoue Y; Yoshida M; Sakamoto S; Miura Y
    Int J Cancer; 1992 Feb; 50(4):604-10. PubMed ID: 1537625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
    Kano Y; Akutsu M; Suzuki K; Yoshida M
    Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of SN-38 in combination with other anticancer agents against Dauji cells].
    Akutsu M; Suzuki K; Tsunoda S; Kano Y; Miura Y
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1607-11. PubMed ID: 8060135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.
    Yazawa Y; Takagi T; Asakura S; Suzuki K; Kano Y
    J Orthop Sci; 1999; 4(3):231-7. PubMed ID: 10370165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines.
    Takagi T; Yazawa Y; Suzuki K; Yamauchi Y; Kano Y
    Invest New Drugs; 1996; 14(4):357-63. PubMed ID: 9157070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line.
    Kano Y; Akutsu M; Kasahara T; Sakamoto S
    Eur J Cancer; 1991; 27(9):1141-5. PubMed ID: 1835625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
    Kano Y; Ohnuma T; Okano T; Holland JF
    Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
    Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
    Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
    Akutsu M; Suzuki K; Tsunoda S; Kano Y
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide.
    Ehninger G; Proksch B; Wanner T; Schuler U; Busch FW; Schmidt H; Schleyer E; Jaschonek K; Hiddemann W
    Leukemia; 1992 Jun; 6(6):582-7. PubMed ID: 1602795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Kawasaki M; Tsuruta N; Mizuno K; Hara N
    Anticancer Drugs; 1997 Mar; 8(3):231-7. PubMed ID: 9095327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
    Schaison G; Leverger G; Bancillon A; Marty M; Olive D; Cornu G; Griscelli C; Lemerle S; Harousseau JL; Bonnet M
    Haematol Blood Transfus; 1987; 30():461-5. PubMed ID: 3305213
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
    Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
    Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of harringtonine in combination with acivicin, adriamycin, L-asparaginase, cytosine arabinoside, dexamethasone, fluorouracil or methotrexate on human acute myelogenous leukemia cell line KG-1.
    Okano T; Ohnuma T; Holland JF; Koeffler HP; Jui H
    Invest New Drugs; 1983; 1(2):145-50. PubMed ID: 6590529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosine arabinoside in experimental combination therapy.
    Edelstein M; Valeriote F
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):75-83. PubMed ID: 3892705
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Mano H; Furukawa Y
    Invest New Drugs; 2007 Feb; 25(1):31-40. PubMed ID: 16865529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.